Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07815132) titled 'Fractional CO2 Laser for Primary Cutaneous Amyloidosis' on Sept. 6.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Tanta University
Condition:
Amyloid
Fractional
Laser
Intervention:
Device: Fractional CO2 Laser
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: September 10, 2024
Target Sample Size: 22
Countries of Recruitment:
Egypt
To know more, visit https://clinicaltrials.gov/study/NCT07815132
Published by HT Digital Content Services wi...